CAH
Cardinal Health
Stock NYSE – Stock Market Prices, News & Analysis
Cardinal Health Inc is a provider of health products and services, including the distribution of pharmaceutical and medical products.
Cardinal Health
CAH
Cardinal Health Inc is a provider of health products and services, including the distribution of pharmaceutical and medical products.
Price history of Cardinal Health
Price history of Cardinal Health
Performance & Momentum
Wells Fargo Raises Price Target for Cardinal Health
Wells Fargo has increased its price target for Cardinal Health (NYSE: CAH) from $237 to $256, maintaining an 'Overweight' rating. This move follows strong Q2 results, highlighting the company's overall robust health. This positive update may support the stock's favorable performance in the short to medium term on the NYSE.
Strategic Analysis
Cardinal Health • 2026
Cardinal Health Inc positions itself as a key player in the logistics chain within the healthcare sector in the United States, specializing in the distribution of pharmaceutical and medical products. Its model relies on extensive coverage and sharp logistical expertise, which are essential for the smooth operation of healthcare facilities.
Strengths
- Robust and integrated logistics network, ensuring efficient and reliable distribution.
- Strategic positioning in a non-substitutable sector, with recurring and resilient demand.
- Ability to capture growth in home healthcare and pharmacy-related services.
Weaknesses
- High dependence on the American market, limiting geographical diversification.
- Constant pressure on margins due to competition and regulation in the pharmaceutical sector.
Momentum
The stock momentum is strong, reflecting growing investor confidence in its consistent operational performance and its positioning in a continuously growing sector. This dynamism suggests an entry opportunity for investors seeking a balance between growth and stability in healthcare.
Similar stocks to Cardinal Health
Recent News
Cardinal Health
Citi Upgrades Cardinal Health with $244 Price Target
2 months agoCardinal Health (CAH) shares rise following Citi's upgrade from 'Neutral' to 'Buy' and price target increase from $190 to $244. The positive outlook highlights CAH as a defensive pick amid recession concerns. The stock recently hit a 52-week high, underscoring investor confidence in its strong fundamentals and medium-term prospects.
Cardinal Health Hits Annual High on Strong Q3 Results
5 months agoCardinal Health (NYSE: CAH) reported third-quarter 2025 results that exceeded expectations, with revenue rising 22.4% to $64.01 billion and non-GAAP EPS of $2.55, beating analyst consensus by 17.3%. Buoyed by this performance, the company raised its full-year 2026 guidance, driving the stock to a new 52-week high. Additionally, the stock's fair value estimate was revised upward, reflecting growing analyst optimism about Cardinal Health's growth prospects.
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
